相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-1 blocks lytic granule polarization with concomitant impairment of integrin outside-in signaling in the natural killer cell immunological synapse
Yu Huang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
From genetics to the clinic: a translational perspective on follicular lymphoma
Sarah Huet et al.
NATURE REVIEWS CANCER (2018)
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
Zijun Y. Xu-Monette et al.
BLOOD (2018)
The emerging role of immune checkpoint inhibition in malignant lymphoma
Ida Hude et al.
HAEMATOLOGICA (2017)
Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody production
Alberto Purwada et al.
NATURE PROTOCOLS (2017)
PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas
Aaron Goodman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The emerging role of immune checkpoint inhibition in malignant lymphoma
Ida Hude et al.
HAEMATOLOGICA (2017)
HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN-LABEL, PHASE II STUDY
L.J. Nastoupil et al.
HEMATOLOGICAL ONCOLOGY (2017)
3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro
Robert G. Mannino et al.
LAB ON A CHIP (2017)
Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-Hodgkin lymphoma: a summary of immunohistochemical studies
Pauline Gravelle et al.
ONCOTARGET (2017)
Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
Marie Tosolini et al.
ONCOIMMUNOLOGY (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Alexander M. Lesokhin et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas
Marie Tosolini et al.
ONCOIMMUNOLOGY (2016)
gamma delta T cell-based anticancer immunotherapy: progress and possibilities
Serena Meraviglia et al.
IMMUNOTHERAPY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Several immune escape patterns in non-Hodgkin's lymphomas
Camille Laurent et al.
ONCOIMMUNOLOGY (2015)
Cell Growth in Aggregates Determines Gene Expression, Proliferation, Survival, Chemoresistance, and Sensitivity to Immune Effectors in Follicular Lymphoma
Pauline Gravelle et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma
Marianne Brodtkorb et al.
BLOOD (2014)
A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the Breast
Oukseub Lee et al.
CLINICAL CANCER RESEARCH (2014)
Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas
Alessandra Musso et al.
HAEMATOLOGICA (2014)
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Charles Butts et al.
LANCET ONCOLOGY (2014)
The yin and the yang of follicular lymphoma cell niches: Role of microenvironment heterogeneity and plasticity
Patricia Ame-Thomas et al.
SEMINARS IN CANCER BIOLOGY (2014)
Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma
Michael R. Green et al.
BLOOD (2013)
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
June H. Myklebust et al.
BLOOD (2013)
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Jean-Jacques Fournie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model
E. Decaup et al.
BLOOD CANCER JOURNAL (2013)
An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma
A. James Watkins et al.
PLOS ONE (2012)
Innate predisposition to immune escape in follicular lymphoma cells
Pauline Gravelle et al.
ONCOIMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria
Etienne Hebert Chatelain et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens
Masashi Iwasaki et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody
Mounia Sabrina Braza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Ekkehard Moessner et al.
BLOOD (2010)
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20
David Dayde et al.
BLOOD (2009)
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function
Fleur Bossi et al.
BLOOD (2009)
High Numbers of Tumor-Infiltrating Programmed Cell Death 1-Positive Regulatory Lymphocytes Are Associated With Improved Overall Survival in Follicular Lymphoma
Joaquim Carreras et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Human γδ T lymphocytes strip and kill tumor cells simultaneously
Julie Gertner et al.
IMMUNOLOGY LETTERS (2007)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors
D de Jong
JOURNAL OF CLINICAL ONCOLOGY (2005)
Profiling blood lymphocyte interactions with cancer cells uncovers the innate reactivity of human γδ T cells to anaplastic large cell lymphoma
M Poupot et al.
JOURNAL OF IMMUNOLOGY (2005)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Synthetic phosphoantigens enhance human Vγ9Vδ2 T lymphocytes killing of non-Hodgkin's B lymphoma
H Sicard et al.
MOLECULAR MEDICINE (2001)
分享论文
